跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX TEVA 100 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUGAMMADEX TEVA 100 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
SUGAMMADEX TEVA 100 MG/ML SOLUCION INYECTABLE EFG
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 5, 2022
Approval ID
0d618891314348c6
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
0d618891314348c6
Drug Cima Aemps Name
SUGAMMADEX TEVA 100 MG/ML SOLUCION INYECTABLE EFG
Register Number
86778
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2022-04-05
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
SUGAMMADEX SODIO
108,8 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 5, 2022
Approval ID
0d618891314348c6
Type
Standard
Back to CIMA-AEMPS Approvals
